Chris Probert

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

Maitreyi Raman, Iftikhar Ahmed, Patrick M. Gillevet et al. · Clinical Gastroenterology and Hepatology · 2013 · 662 citations

Obesity, Metabolic Syndrome, Dysbiosis +14

Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease

Catherine E. Garner, Stephen J. Smith, Ben de Lacy Costello et al. · The FASEB Journal · 2007 · 431 citations · Full text

Persistent Organic Pollutant, Medicine, Chemical Contaminants +11

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

Nicholas A. Kennedy, Gareth‐Rhys Jones, Christopher A Lamb et al. · Gut · 2020 · 255 citations · Full text

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 229 citations · Full text

Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases.

Chris Probert, Iftikhar Ahmed, Tanzeela Khalid et al. · PubMed · 2009 · 167 citations

Diagnostic Biomarkers, Metabolomic Profiling, Forensic Chemistry +22